1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Vallejo A, Martín-Hondarza A, Gómez S, Velasco H, Vizcarra P, Haemmerle J, Casado JL.

    Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

    FRONTIERS IN MICROBIOLOGY . 12: 812729-812729. Nº de citas: 6

    [doi:10.3389/fmicb.2021.812729]

  • Ruiz-Galiana, Julian, de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Canton, Rafael, Bouza, Emilio.

    Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(1): 1-6. Nº de citas: 5

    [doi:10.37201/req/129.2021]

  • de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Ruiz-Galiana, Julian, Canton, Rafael, Bouza, Emilio.

    Actions and attitudes on the immunized patients against SARS-CoV-2

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(1): 7-15. Nº de citas: 2

    [doi:10.37201/req/131.2021]

  • Del Amo J, Polo R, Moreno S, Jarrín I, Hernán MA.

    SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment

    AIDS . 36(2): 161-168. Nº de citas: 29

    [doi:10.1097/QAD.0000000000003132]

  • Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J, REIPI-GEIRAS-FOREST group.

    Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.

    Jama Network Open . 5(1): . Nº de citas: 55

    [doi:10.1001/jamanetworkopen.2021.37277]

  • Pintado V, Ruiz-Garbajosa P, Escudero R, Gioia F, Herrera S, Vizcarra P, Fortún J, Cobo J, Martín-Dávila P, Morosini MI, Cantón R, Moreno S.

    Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    INFECTIOUS DISEASES . 54(1): 36-45. Nº de citas: 29

    [doi:10.1080/23744235.2021.1963471]

  • Gosalbes MJ, Jimenéz-Hernandéz N, Moreno E, Artacho A, Pons X, Ruíz-Pérez S, Navia B, Estrada V, Manzano M, Talavera-Rodriguez A, Madrid N, Vallejo A, Luna L, Pérez-Molina JA, Moreno S, Serrano-Villar S.

    Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.

    Gut Microbes . 14(1): 2089002-2089002. Nº de citas: 19

    [doi:10.1080/19490976.2022.2089002]

  • Brañas F, Galindo MJ, Torralba M, Antela A, Vergas J, Ramírez M, Ryan P, Dronda F, Busca C, Machuca I, Bustinduy MJ, Cabello A, Sánchez-Conde M.

    Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

    Plos One . 17(3): . Nº de citas: 13

    [doi:10.1371/journal.pone.0266191]

  • Casado JL, Moraga E, Vizcarra P, Velasco H, Martín-Hondarza A, Haemmerle J, Gómez S, Quereda C, Vallejo A.

    Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

    VIRUSES-BASEL . 14(1): . Nº de citas: 18

    [doi:10.3390/v14010046]

  • Martínez-Sanz J, Serrano-Villar S, Vivancos MJ, Rubio R, Moreno S.

    Management of Comorbidities in Treated HIV Infection: A Long Way to Go HIV, comorbidities and aging

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 59(1): 106493-106493. Nº de citas: 26

    [doi:10.1016/j.ijantimicag.2021.106493]

  • Otheo E, Rodríguez M, Moraleda C, Domínguez-Rodríguez S, Martín MD, Herreros ML, Vázquez C, Folgueira MD, Pérez-Rivilla A, Jensen J, López A, Berzosa A, Sanz de Santaeufemia FJ, Jiménez AB, Sainz T, Llorente M, Santos M, Garrote E, Muñoz C, Sánchez P, Illán M, Coca A, Barrios A, Pacheco M, Arquero C, Gutiérrez L, Epalza C, Rojo P, Serna-Pascual M, Mota I, Moreno S, Galán JC, Tagarro A.

    Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    PEDIATRIC PULMONOLOGY . 57(1): 253-263. Nº de citas: 18

    [doi:10.1002/ppul.25721]

  • Pérez-Elías MJ, Podzamczer Palter D, Ventayol Bosch P, Jarrín I, Castro A, Rubio-Rodríguez D, Rubio-Terrés C.

    Clinical and economic benefit of 32 years of antiretroviral treatment for people living with HIV in Spain: Has it been an efficient intervention?

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 40(10): 550-556. Nº de citas: 1

    [doi:10.1016/j.eimce.2021.05.011]

  • Vizcarra P, Haemmerle J, Velasco H, Velasco T, Fernández-Escribano M, Vallejo A, Casado JL.

    BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity

    Vaccine . 39(51): 7367-7374. Nº de citas: 2

    [doi:10.1016/j.vaccine.2021.10.074]

  • Díaz-Álvarez J, Roiz P, Gorospe L, Ayala A, Pérez-Pinto S, Martínez-Sanz J, Sánchez-Conde M, Casado JL, Pérez-Elías MJ, Moreno A, Ron R, Vivancos MJ, Vizcarra P, Moreno S, Serrano-Villar S.

    Implementation of a lung cancer screening initiative in HIV-infected subjects.

    Plos One . 16(12): . Nº de citas: 1

    [doi:10.1371/journal.pone.0260069]

  • Fernández-de-Bobadilla MD, Talavera-Rodríguez A, Chacón L, Baquero F, Coque TM, Lanza VF.

    PATO: Pangenome Analysis Toolkit

    Bioinformatics . 37(23): 4564-4566. Nº de citas: 3

    [doi:10.1093/bioinformatics/btab697]

  • Gómez-Zorrilla S, Becerra-Aparicio F, López Montesinos I, Ruiz de Gopegui E, Grau I, Pintado V, Padilla B, Benito N, Boix-Palop L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Durán-Jordá X, Díaz-Regañón J, López-Mendoza D, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP, REIPI/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group.

    A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    Infectious diseases and therapy . 10(4): 2677-2699. Nº de citas: 1

    [doi:10.1007/s40121-021-00537-0]

  • Gogishvili M, Huang TT, Costa SA, Florez K, Mateu-Gelabert P, Valls MRA, Rivero M, Saumoy M, Samperiz G, Cervero M, Pulido F, Pérez JA, Cohort of the Spanish AIDs Research Network.

    Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15.

    EUROPEAN JOURNAL OF PUBLIC HEALTH . 31(6): 1123-1128.

    [doi:10.1093/eurpub/ckab089]

  • Patel R, Evitt L, Mariolis I, Di Giambenedetto S, d'Arminio Monforte A, Casado J, Cabello Úbeda A, Hocqueloux L, Allavena C, Barber T, Jha D, Kumar R, Kamath RD, Vincent T, van Wyk J, Koteff J.

    HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.

    Infectious diseases and therapy . 10(4): 2051-2070. Nº de citas: 7

    [doi:10.1007/s40121-021-00522-7]